NICE offer PGD good practice guideline
NICE has published good practice guidance on Patient Group Directions (PGDs). The guidance has been developed to help individuals and organisations who are considering the need for, developing, authorising, using and/or updating PGDs to ensure they are appropriate, legal and that relevant governance arrangements are in place within commissioning and provider organisations.Some public content. The guidance underlines that supplying and/or administering medicines under PGD should be reserved for situations where this offers an advantage for patient care without compromising patient safety and where there are clear governance arrangements and accountability.
Professor Mark Baker, Director of the Centre for Clinical Practice at NICE commented:
“The majority of clinical care should be provided on an individual, patient-specific basis. Prescribing to a named patient after the prescriber has assessed the patient on an individual basis remains the preferred option for the majority of care – PGDs should not be seen as a direct substitute for prescribing.”
PGDs provide a legal framework that allows some medicines to be supplied and/or administered by named, authorised, registered health professionals, to a pre-defined group of patients needing preventative treatment or treatment for a condition without the need for a prescription.
All of the resources on the Medicines & Prescribing section of the NICE website are available by following this link http://www.nice.org.uk/mpc/index.jsp